Protexi

N/A

Report date: 2026/04/28 20:00:22

Base Information

Drug NameProtexi

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineVaccines > Application > Therapeutic vaccine +[5]

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsSarcoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCelloram Inc

China Registration ClassN/A

Develop Information

Active CompaniesCelloram Inc

Inactive CompaniesN/A

Active IndicationsSarcoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A